Kyle Rasbach insider trades
Open-market stock purchases and sales by Kyle Rasbach, Chief Financial Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Jan 17, 2025.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- LXEO Lexeo Therapeutics, Inc: other filings, last Jan 17, 2025